Provided by Tiger Trade Technology Pte. Ltd.

iShares MSCI Pacific ex Japan ETF

57.79
+0.07000.12%
Post-market: 57.790.00000.00%16:10 EDT
Volume:319.47K
Turnover:18.47M
Market Cap:2.32B
PE:6.80
High:58.03
Open:58.03
Low:57.75
Close:57.72
52wk High:58.56
52wk Low:48.93
Shares:40.20M
Float Shares:40.20M
Volume Ratio:1.77
T/O Rate:0.79%
Dividend:1.87
Dividend Rate:3.23%
EPS(TTM):8.50
EPS(LYR):8.50
ROE:25.94%
ROA:1.81%
PB:1.08
PE(LYR):6.80

Loading ...

AIA Group Stock Climbs 2.3% in Hong Kong

Dow Jones
·
Jul 14

Monetary Authority of Singapore's July Meeting Looks Increasingly 'live'

Dow Jones
·
Jul 14

Inflation is NOT coming from commodity prices: Larry Berman

Bloomberg
·
Jul 14

SCENESSE® approved for EPP in Canada

GlobeNewswire
·
Jul 13

Clinuvel Pharmaceuticals' Photoprotection Drug Candidate Receives Health Canada Approval

MT Newswires Live
·
Jul 13

Dahua Jixian Adjusts AIA's Price Target to HK$100, Reaffirms "Buy" Amid Anticipated 13% Q2 VONB Growth

Stock News
·
Jul 10

Auckland International Airport (NZSE:AIA) Following Its Master Plan Gets A Valuation Reality Check

Simply Wall St.
·
Jul 10

Australian Equities Roundup

Dow Jones
·
Jul 09

Hong Kong Market Stands Firm Amid Global Turmoil; Domestic Substitution Accelerates on Catalysts

Stock News
·
Jul 08

AIA Group Stock Slides 1.9% in Hong Kong

Dow Jones
·
Jul 07

Weaker commodity prices set to tip Australia into trade deficit

James Mayger / Bloomberg
·
Jul 06

Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting

GlobeNewswire
·
Jun 12

Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria

GlobeNewswire
·
Jun 09

Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients

GlobeNewswire
·
Jun 01

Press Release: Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
May 05

CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study

GlobeNewswire
·
Apr 24

CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026

GlobeNewswire
·
Apr 15

Clinuvel Leverages AAD 2026 to Advance Vitiligo, EPP Strategy and U.S. Profile

TIPRANKS
·
Apr 02

Clinuvel Showcases AI Vitiligo Tool and EPP Therapy at Major U.S. Dermatology Meeting

TIPRANKS
·
Mar 27